HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon and Gillette post first quarter double-digit sales gains.

This article was originally published in The Rose Sheet

Executive Summary

AVON MEXICO FIRST QUARTER PRETAX PROFITS REDUCED BY ABOUT $10 MIL. primarily due to the devaluation of the Mexican peso, the company announced April 20. However, Avon Chairman and CEO James Preston noted, "we think the worst is behind us in Mexico and the currency impact should lessen in succeeding quarters because of revised marketing and sales plans being implemented there." At a March 30 analysts' meeting in New York City, Avon predicted "a significant gain in market share in most of the categories in which we compete" in Mexico in 1995 ("The Rose Sheet" April 3, p. 10)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel